UB Paderborn / Katalog / Suche / in CDI

Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2003-12, Vol.47 (12), p.3907-3916

2003

Volltextzugriff (PDF)

In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease

Antimicrobial Agents and Chemotherapy, 2005-06, Vol.49 (6), p.2267-2275

2005

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics

Journal of medicinal chemistry, 2002-04, Vol.45 (8), p.1607-1623

2002

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing Peptidomimetics

Journal of medicinal chemistry, 2003-10, Vol.46 (21), p.4572-4585

2003

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. Part 7: Structure–Activity Studies of Bicyclic 2-Pyridone-Containing Peptidomimetics

Bioorganic & medicinal chemistry letters, 2002-03, Vol.12 (5), p.733-738

2002

Volltextzugriff (PDF)

Structure-Based Design of a Parallel Synthetic Array Directed Toward the Discovery of Irreversible Inhibitors of Human Rhinovirus 3C Protease

Journal of medicinal chemistry, 2002-05, Vol.45 (10), p.2016-2023

2002

Volltextzugriff (PDF)

Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors

Bioorganic & medicinal chemistry letters, 2000-01, Vol.10 (1), p.45-48

2000

Volltextzugriff (PDF)

An optical thin film assay incorporating rhinovirus protease inhibitors as detector reagents

Antiviral research, 2004-03, Vol.61 (3), p.153-159

2004

Volltextzugriff (PDF)

Isolation of a Human Erythrocyte Membrane Protein Capable of Inhibiting Expression of Homologous Complement Transmembrane Channels

Proceedings of the National Academy of Sciences - PNAS, 1986-09, Vol.83 (18), p.6975-6979

1986

Volltextzugriff (PDF)

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria

The Journal of experimental medicine, 1987-02, Vol.165 (2), p.572-577

1987

Volltextzugriff (PDF)

Comparison of human cytomegalovirus (HCMV) protease sequences among laboratory strains and seven clinical isolates

Antiviral research, 1997-02, Vol.33 (3), p.215-218

1997

Volltextzugriff (PDF)

Mechanism of Cytotoxicity of Human Large Granular Lymphocytes: Relationship of the Cytotoxic Lymphocyte Protein to the Ninth Component (C9) of Human Complement

Proceedings of the National Academy of Sciences - PNAS, 1986-07, Vol.83 (14), p.5262-5266

1986

Volltextzugriff (PDF)

Homologous restriction factor: Effect on complement C8 and C9 uptake and lysis

Molecular immunology, 1994-03, Vol.31 (4), p.301-305

1994

Volltextzugriff (PDF)

Self-Protection of Cytotoxic Lymphocytes: A Soluble Form of Homologous Restriction Factor in Cytoplasmic Granules

Proceedings of the National Academy of Sciences - PNAS, 1988-07, Vol.85 (13), p.4827-4831

1988

Volltextzugriff (PDF)

Inhibition of cytolytic lymphocytes by homologous restriction factor. Lack of species restriction

The Journal of immunology (1950), 1991-06, Vol.146 (12), p.4278

1991

Volltextzugriff (PDF)

Induction of Expression of Cell-Surface Homologous Restriction Factor upon Anti-CD3 Stimulation of Human Peripheral Lymphocytes

Proceedings of the National Academy of Sciences - PNAS, 1988-01, Vol.85 (1), p.213-217

1988

Volltextzugriff (PDF)

Induction of Synthesis of the Cytolytic C9 (Ninth Component of Complement)-Related Protein in Human Peripheral Mononuclear Cells by Monoclonal Antibody OKT3 or Interleukin 2: Correlation with Cytotoxicity and Lymphocyte Phenotype

Proceedings of the National Academy of Sciences - PNAS, 1987-05, Vol.84 (9), p.2946-2950

1987

Volltextzugriff (PDF)

The Cytolytic Protein of Human Lymphocytes Related to the Ninth Component (C9) of Human Complement: Isolation from Anti-CD3-Activated Peripheral Blood Mononuclear Cells

Proceedings of the National Academy of Sciences - PNAS, 1987-04, Vol.84 (8), p.2426-2429

1987

Volltextzugriff (PDF)

A C9 related channel forming protein in the cytoplasmic granules of human large granular lymphocytes

Bioscience reports, 1985-12, Vol.5 (12), p.1093-1100

1985

Volltextzugriff (PDF)

Molecular Mechanisms of Cytotoxicity: Comparison of Complement and Killer Lymphocytes

Progress in Immunology VI, 1986, p.268-281

1986

Volltextzugriff (PDF)

A behind‐the‐scenes tour of the IEDB curation process: an optimized process empirically integrating automation and human curation efforts

Immunology, 2020-10, Vol.161 (2), p.139-147

2020

Volltextzugriff (PDF)

Rapid multiserotype detection of human rhinoviruses on optically coated silicon surfaces

Journal of clinical virology, 2001-05, Vol.21 (2), p.105-117

2001

Volltextzugriff (PDF)

Mechanism of Insertion of Diphtheria Toxin: Peptide Entry and Pore Size Determinations

Proceedings of the National Academy of Sciences - PNAS, 1984-06, Vol.81 (11), p.3341-3345

1984

Volltextzugriff (PDF)

Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement

Molecular immunology, 1990-06, Vol.27 (6), p.533-537

1990

Volltextzugriff (PDF)

PORE-FORMING PROTEINS OF BACTERIAL AND MITOCHONDRIAL OUTER MEMBRANE

ZALMAN, LEORA SHALTIEL

1982

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy Volunteers

In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing Peptidomimetics

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. Part 7: Structure–Activity Studies of Bicyclic 2-Pyridone-Containing Peptidomimetics

Structure-Based Design of a Parallel Synthetic Array Directed Toward the Discovery of Irreversible Inhibitors of Human Rhinovirus 3C Protease

Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors

An optical thin film assay incorporating rhinovirus protease inhibitors as detector reagents

Isolation of a Human Erythrocyte Membrane Protein Capable of Inhibiting Expression of Homologous Complement Transmembrane Channels

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria

Comparison of human cytomegalovirus (HCMV) protease sequences among laboratory strains and seven clinical isolates

Mechanism of Cytotoxicity of Human Large Granular Lymphocytes: Relationship of the Cytotoxic Lymphocyte Protein to the Ninth Component (C9) of Human Complement

Homologous restriction factor: Effect on complement C8 and C9 uptake and lysis

Self-Protection of Cytotoxic Lymphocytes: A Soluble Form of Homologous Restriction Factor in Cytoplasmic Granules

Inhibition of cytolytic lymphocytes by homologous restriction factor. Lack of species restriction

Induction of Expression of Cell-Surface Homologous Restriction Factor upon Anti-CD3 Stimulation of Human Peripheral Lymphocytes

Induction of Synthesis of the Cytolytic C9 (Ninth Component of Complement)-Related Protein in Human Peripheral Mononuclear Cells by Monoclonal Antibody OKT3 or Interleukin 2: Correlation with Cytotoxicity and Lymphocyte Phenotype

The Cytolytic Protein of Human Lymphocytes Related to the Ninth Component (C9) of Human Complement: Isolation from Anti-CD3-Activated Peripheral Blood Mononuclear Cells

A C9 related channel forming protein in the cytoplasmic granules of human large granular lymphocytes

Molecular Mechanisms of Cytotoxicity: Comparison of Complement and Killer Lymphocytes

A behind‐the‐scenes tour of the IEDB curation process: an optimized process empirically integrating automation and human curation efforts

Rapid multiserotype detection of human rhinoviruses on optically coated silicon surfaces

Mechanism of Insertion of Diphtheria Toxin: Peptide Entry and Pore Size Determinations

Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement

PORE-FORMING PROTEINS OF BACTERIAL AND MITOCHONDRIAL OUTER MEMBRANE

Suchergebnisse filtern